FULLER & THALER ASSET MANAGEMENT, INC.
Position in ELAN — Elanco Animal Health Inc
CIK 1082327
SAN MATEO, CA
Position in ELAN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$143,940,481
+$13,328,676 QoQ
Shares Held
6,015,064
+4.2% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 94.33289487859147.ToString("F0")%
Shared 0.ToString("F0")%
None 5.667105121408517.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $650,343,348 across 12 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
280,405 | $166,274,556 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
6,015,064 | $143,940,481 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,529,583 | $138,061,689 | |
| 4 | PRGO |
PERRIGO Co plc
|
7,662,883 | $82,299,363 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
1,499,584 | $49,591,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
1,419,677 | $29,472,494 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,395,139 | $27,330,773 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
87,350 | $11,507,489 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $143,940,481 | 6,015,064 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $130,611,805 | 5,771,622 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $100,133,602 | 4,971,877 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $72,866,570 | 5,102,701 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||